BHC vs. TLRY, CRON, WEED, DNTL, SIA, GUD, ACB, OGI, CPH, and CRDL
Should you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Tilray Brands (TLRY), Cronos Group (CRON), Canopy Growth (WEED), dentalcorp (DNTL), Sienna Senior Living (SIA), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Organigram (OGI), Cipher Pharmaceuticals (CPH), and Cardiol Therapeutics (CRDL). These companies are all part of the "medical" sector.
Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.
Tilray Brands has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
In the previous week, Tilray Brands had 1 more articles in the media than Bausch Health Companies. MarketBeat recorded 1 mentions for Tilray Brands and 0 mentions for Bausch Health Companies. Tilray Brands' average media sentiment score of 0.00 beat Bausch Health Companies' score of -0.50 indicating that Tilray Brands is being referred to more favorably in the news media.
Bausch Health Companies presently has a consensus price target of C$9.00, indicating a potential downside of 7.41%. Tilray Brands has a consensus price target of C$2.95, indicating a potential upside of 7.66%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies.
Bausch Health Companies has a net margin of -5.07% compared to Tilray Brands' net margin of -47.35%. Tilray Brands' return on equity of -9.69% beat Bausch Health Companies' return on equity.
Bausch Health Companies received 39 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 66.10% of users gave Bausch Health Companies an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.
Bausch Health Companies has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500.
80.9% of Bausch Health Companies shares are held by institutional investors. Comparatively, 10.5% of Tilray Brands shares are held by institutional investors. 0.9% of Bausch Health Companies shares are held by company insiders. Comparatively, 1.3% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
Tilray Brands beats Bausch Health Companies on 10 of the 16 factors compared between the two stocks.
Get Bausch Health Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bausch Health Companies Competitors List
Related Companies and Tools
